Logos Global Management LP Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1.2T
Holdings
53
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SRPTSAREPTA THERAPEUTICS INC | 1,600,000 | $207.1B | 16.76% | Call |
| 2 | ALNYALNYLAM PHARMACEUTICALS INC | 500,000 | $74.7B | 6.05% | Call |
| 3 | IDYAIDEAYA BIOSCIENCES INC | 1,500,000 | $65.8B | 5.33% | |
| 4 | IMCRIMMUNOCORE HLDGS PLC | 900,000 | $58.5B | 4.73% | |
| 5 | IMVTIMMUNOVANT INC | 1,775,000 | $57.4B | 4.64% | |
| 6 | OCULOCULAR THERAPEUTIX INC | 5,811,436 | $52.0B | 4.21% | |
| 7 | GPCRSTRUCTURE THERAPEUTICS INC | 1,170,058 | $50.1B | 4.06% | Call |
| 8 | OLMAOLEMA PHARMACEUTICALS INC | 4,383,875 | $49.6B | 4.02% | |
| 9 | DYNDYNE THERAPEUTICS INC | 1,730,000 | $49.1B | 3.98% | |
| 10 | APLSAPELLIS PHARMACEUTICALS INC | 800,000 | $47.0B | 3.81% | |
| 11 | RCKTROCKET PHARMACEUTICALS INC | 1,300,000 | $35.0B | 2.83% | |
| 12 | CATBUSDASTRIA THERAPEUTICS INC | 2,244,960 | $31.6B | 2.56% | Call |
| 13 | SLNSILENCE THERAPEUTICS PLC | 1,476,061 | $31.1B | 2.52% | |
| 14 | GONGERON CORP | 9,000,000 | $29.7B | 2.40% | |
| 15 | ANNXANNEXON INC | 4,050,000 | $29.0B | 2.35% | Call |
| 16 | TCE2CELLDEX THERAPEUTICS INC NEW | 650,000 | $27.3B | 2.21% | |
| 17 | ELVNENLIVEN THERAPEUTICS INC | 1,574,220 | $26.4B | 2.14% | |
| 18 | VERAVERA THERAPEUTICS INC | 575,000 | $24.8B | 2.01% | |
| 19 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,499,999 | $21.2B | 1.72% | |
| 20 | DSGNDESIGN THERAPEUTICS INC | 5,032,501 | $20.3B | 1.64% | |
| 21 | AKROAKERO THERAPEUTICS INC | 800,000 | $20.2B | 1.64% | |
| 22 | CYBNEURCYBIN INC | 40,000,000 | $16.5B | 1.34% | |
| 23 | XNCRXENCOR INC | 650,000 | $14.4B | 1.16% | |
| 24 | CGONCG ONCOLOGY INC | 300,000 | $13.2B | 1.07% | |
| 25 | ENGNENGENE HOLDINGS INC | 800,000 | $12.9B | 1.04% | |
| 26 | KYTXKYVERNA THERAPEUTICS INC | 500,000 | $12.4B | 1.01% | |
| 27 | VRDNVIRIDIAN THERAPEUTICS INC | 700,000 | $12.3B | 0.99% | |
| 28 | CGEMCULLINAN ONCOLOGY INC | 700,000 | $11.9B | 0.97% | |
| 29 | IMTXIMMATICS N.V | 1,000,000 | $10.5B | 0.85% | |
| 30 | SYRESPYRE THERAPEUTICS INC | 250,000 | $9.5B | 0.77% | |
| 31 | FULCFULCRUM THERAPEUTICS INC | 1,000,000 | $9.4B | 0.76% | Call |
| 32 | LCTXLINEAGE CELL THERAPEUTICS IN | 6,250,000 | $9.3B | 0.75% | |
| 33 | PRAXPRAXIS PRECISION MEDICINES I | 150,000 | $9.2B | 0.74% | |
| 34 | APLTAPPLIED THERAPEUTICS INC | 1,350,000 | $9.0B | 0.73% | |
| 35 | SNDXSYNDAX PHARMACEUTICALS INC | 350,000 | $8.3B | 0.67% | |
| 36 | TRVITREVI THERAPEUTICS INC | 2,200,000 | $7.6B | 0.61% | |
| 37 | CYTKCYTOKINETICS INC | 100,000 | $7.0B | 0.57% | |
| 38 | KURAKURA ONCOLOGY INC | 300,000 | $6.4B | 0.52% | |
| 39 | NMRANEUMORA THERAPEUTICS INC. | 382,345 | $6.2B | 0.50% | |
| 40 | ATYRATYR PHARMA INC | 3,100,000 | $6.0B | 0.49% | |
| 41 | JANXJANUX THERAPEUTICS INC | 150,000 | $5.6B | 0.46% | |
| 42 | LRMRLARIMAR THERAPEUTICS INC | 700,000 | $5.3B | 0.43% | Call |
| 43 | —ELEVATION ONCOLOGY INC | 1,000,000 | $5.1B | 0.42% | |
| 44 | NXTCNEXTCURE INC | 1,925,000 | $4.3B | 0.35% | |
| 45 | ALLKGUSDALLAKOS INC | 2,900,000 | $3.7B | 0.30% | |
| 46 | UNCYUNICYCIVE THERAPEUTICS INC | 3,469,927 | $3.0B | 0.24% | |
| 47 | BOLDBOUNDLESS BIO INC | 200,000 | $2.9B | 0.23% | |
| 48 | TRMLTOURMALINE BIO INC | 99,208 | $2.3B | 0.18% | |
| 49 | CMPSCOMPASS PATHWAYS PLC | 257,980 | $1.8B | 0.15% | |
| 50 | IOBTIO BIOTECH INC | 493,827 | $854.3M | 0.07% | |
| 51 | IMUXIMMUNIC INC | 421,184 | $556.0M | 0.04% | |
| 52 | CYPHLEAP THERAPEUTICS INC | 39,500 | $105.1M | 0.01% | |
| 53 | NUVB/WSNUVATION BIO INC | 66,666 | $22.7M | 0.00% |